// App-Quantinova.ai

55 : Effectiveness and Safety of Golimumab in the Treatment of Rheumatoid Arthritis over a 24 Month Period

Researchers

Presenter

  • John Kelsall

Principal Investigators

  • Denis Choquette

  • Karina Maslova

  • Cathy Tkaczyk

  • Allen Lehman

  • Brendan Osborne

  • Maqbool Sheriff

  • Andrew Chow

  • Dalton Sholter

  • Isabelle Fortin

  • Milton Baker

  • Emmanouil Rampakakis

  • Eliofotisti Psaradellis

  • Francois Nantel

Medical Centers

  • University of Alberta, Edmonton, AB, Canada

  • CH Rimouski, Rimouski,Canada

  • Credit Valley Rheumatology, Mississauga, ON, Canada

  • Mary Pack Arthritis Centre, Vancouver, Vancouver, BC, Canada

  • University of Victoria, Victoria, BC, Canada

  • McMaster University, St Joseph's Healthcare Hamilton, Hamilton, ON, Canada

  • Nanaimo Regional Hospital, Nanaimo,Canada

Locations

  • Canada

Companies

  • JSS Medical Research

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Ankylosing spondylitis

  • Rheumatoid arthritis

  • Inflammatory Arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Infliximab

  • golimumab

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved